Immunic IMUX
NASDAQ IMUX
$8.12 +0.08 (+1.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Immunic (IMUX) Shares Outstanding (Diluted) (2019 - 2026)

Updated

Immunic's Weighted Average Shares Outstanding (Diluted) was 42.51 million in Q2 2026, up 221.6% from 13.22 million a year earlier and up 41.1% from the prior quarter.

Analysis

Immunic (IMUX) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, Weighted Average Shares Outstanding (Diluted) at Immunic came in at 15.57 million, up 55.4% from FY2024.

  • Weighted Average Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 58.3% (FY2020 to FY2025).
  • In earlier years, Weighted Average Shares Outstanding (Diluted) was 10.02 million in FY2024 (+126.0%), 4.43 million in FY2023 (+39.3%), 3.18 million in FY2022 (+34.5%) and 2.37 million in FY2021 (+51.0%).
  • The Q2 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q1 2019.
  • Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 19 straight quarters, with growth averaging 106.7% over the last eight quarters.
  • The best year-over-year quarter for Weighted Average Shares Outstanding (Diluted) over five years was Q2 2026 (growth of 221.6%); the worst was Q3 2021 (a decline of 42.1%).
  • Per Business Quant data, IMUX's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 30.14 million (Q1 2026), 15.57 million (Q4 2025) and 19.39 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.45 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.96 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.25 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.75 Bn
10 Immunic 341.81 Mn -50.53 Mn - 42.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.51 Mn
Mar 31, 2026 30.14 Mn
Dec 31, 2025 15.57 Mn
Sep 30, 2025 19.39 Mn
Jun 30, 2025 13.22 Mn
Mar 31, 2025 10.13 Mn
Dec 31, 2024 10.02 Mn
Sep 30, 2024 10.13 Mn
Jun 30, 2024 10.13 Mn
Mar 31, 2024 9.73 Mn
Dec 31, 2023 4.43 Mn
Sep 30, 2023 4.46 Mn
Jun 30, 2023 4.44 Mn
Mar 31, 2023 4.37 Mn
Dec 31, 2022 3.18 Mn
Sep 30, 2022 3.06 Mn
Jun 30, 2022 3.02 Mn
Mar 31, 2022 2.81 Mn
Dec 31, 2021 2.37 Mn
Sep 30, 2021 2.53 Mn
API Access

Immunic Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMUX&period=max&api_key=YOUR_API_KEY